Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fayers
Madeleine King

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Palliative Medicine|December 26, 2003
Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patientsPål Klepstad, Petter C Borchgrevink, Ola Dale, et al.
International Journal of Colorectal Disease|December 3, 2009
Assessment of body image in patients undergoing surgery for colorectal cancerRobert N Whistance, Rebecca Gilbert, Peter Fayers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 2015
Mode of administration does not cause bias in patient-reported outcome results: a meta-analysisClaudia Rutherford, Daniel Costa, Rebecca Mercieca-Bebber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2006
Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastasesStein Kaasa, Elisabeth Brenne, Jo-Asmund Lund, et al.
The Oncologist|August 23, 2013
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancerBarry J Laird, Donald C McMillan, Peter Fayers, et al.
European Urology|March 12, 2014
Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancerJane M Blazeby, Emma Hall, Neil K Aaronson, et al.
BMJ Supportive & Palliative Care|July 19, 2018
Sleep quality with WHO Step III opioid use for cancer painGunnhild Jakobsen, Morten Engstrøm, Peter Fayers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2013
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic systemBarry J Laird, Stein Kaasa, Donald C McMillan, et al.
Clinical Trials (London, England)|November 11, 2017
A systematic review and development of a classification framework for factors associated with missing patient-reported outcome dataMichael J Palmer, Rebecca Mercieca-Bebber, Madeleine King, et al.
The Journal of Physiology|June 18, 2025
Running toward brain health: How aerobic capacity and liver metabolism shape Alzheimer's pathologyEvelin Melekh, Madeleine King, Julia G Stante, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Palliative Medicine|December 26, 2003
Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patientsPål Klepstad, Petter C Borchgrevink, Ola Dale, et al.
International Journal of Colorectal Disease|December 3, 2009
Assessment of body image in patients undergoing surgery for colorectal cancerRobert N Whistance, Rebecca Gilbert, Peter Fayers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 2015
Mode of administration does not cause bias in patient-reported outcome results: a meta-analysisClaudia Rutherford, Daniel Costa, Rebecca Mercieca-Bebber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2006
Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastasesStein Kaasa, Elisabeth Brenne, Jo-Asmund Lund, et al.
The Oncologist|August 23, 2013
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancerBarry J Laird, Donald C McMillan, Peter Fayers, et al.
European Urology|March 12, 2014
Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancerJane M Blazeby, Emma Hall, Neil K Aaronson, et al.
BMJ Supportive & Palliative Care|July 19, 2018
Sleep quality with WHO Step III opioid use for cancer painGunnhild Jakobsen, Morten Engstrøm, Peter Fayers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2013
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic systemBarry J Laird, Stein Kaasa, Donald C McMillan, et al.
Clinical Trials (London, England)|November 11, 2017
A systematic review and development of a classification framework for factors associated with missing patient-reported outcome dataMichael J Palmer, Rebecca Mercieca-Bebber, Madeleine King, et al.
The Journal of Physiology|June 18, 2025
Running toward brain health: How aerobic capacity and liver metabolism shape Alzheimer's pathologyEvelin Melekh, Madeleine King, Julia G Stante, et al.
Pageof 18